Encouraging Emergency Preparedness, UHC and Routine Kidney Assessments – the ISN Makes Its Voice Count at the 152nd Session of the WHO Executive Board
The ISN submitted three statements supporting global kidney health when it participated in the 152nd session of the World Health Organization’s Executive Board from January 30 to February 7, 2023. This annual meeting gathers WHO executive board members at the start of each year to agree on World Health Assembly agenda resolutions for consideration by the Health Assembly.
Working alongside members of the Global Coalition for Circulatory Health (GCCH) the ISN co-signed a statement on strengthening WHO preparedness for and response to health emergencies, calling on member states to prioritize ongoing prevention, screening, and treatment for circulatory conditions in national COVID-19 response and recovery plans.
The ISN submitted an additional joint statement with the GCCH highlighting the importance of accelerating progress toward Universal Health Coverage (UHC) through robust and well-financed primary healthcare systems.
The ISN’s individual statement on the draft updated menu of policy options and cost-effective interventions for the prevention and control of noncommunicable diseases exhorted the WHO and its member states to improve the prevention of kidney disease by routinely assessing kidney function and albuminuria in people with cardiovascular disease, hypertension and diabetes to favor early diagnosis and treatment.
As a non-state actor in official relations with the WHO, and the world’s only international kidney society, the ISN continues to make its voice count in promoting kidney health worldwide.
